Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Norwalk GI.1 Virus Challenge Model Characterization
NCT03721549Phase 1Completed
- Sponsor
- WCCT Global
- Start
- Oct 2018
- Primary completion
- Nov 2018
- Countries
- 1
01
Overview
Phase 1, open-label trial (2 arms), sponsored by WCCT Global. Primary endpoint: Frequency of Norovirus Gastroenteritis. Started Oct 2018; status: completed.
Beyond the preview
Go deeper on NCT03721549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03721549.